Home › Research › Risk factors
A systemic review of the roles of n-3 fatty acids in health and disease
Riediger ND, Othman RA, Suh M, Moghadasian MH.. Journal of the American Dietetic Association, 2009-04-01
Topic: Risk, prevention and care in population studies
Plain-language summary
Attention to the role of n-3 long-chain fatty acids in human health and disease has been continuously increased during recent decades. Many clinical and epidemiologic studies have shown positive roles for n-3 fatty acids in infant development; cancer; cardiovascular diseases; and more recently, in various mental illnesses, including depression, attention-deficit hyperactivity disorder, and dementia. These fatty acids are known to have pleiotropic effects, including effects against inflammation, platelet aggregation, hypertension, and hyperlipidemia. These beneficial effects may be mediated through several distinct mechanisms, including alterations in cell membrane composition and function, gene expression, or eicosanoid production. A number of authorities have recently recommended increases in intakes of n-3 fatty acids by the general population. To comply with this recommendation a variety of food products, most notably eggs, yogurt, milk, and spreads have been enriched with these fatty acids. Ongoing research will further determine the tissue distribution, biological effects, cost-effectiveness, and consumer acceptability of such enriched products. Furthermore, additional controlled clinical trials are needed to document whether long-term consumption or supplementation with eicosapentaenoic acid/docosahexaenoic acid or the plant-derived counterpart (alpha-linolenic acid) results in better quality of life.
What this study adds
Evidence grade: Low
This is a pooled review. This review says n-3 fatty acids have been studied for several conditions including dementia, but that more controlled trials are needed to show whether long-term consumption or supplements improve quality of life. It provides no evidence that these fatty acids treat or prevent Alzheimer's disease.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Riediger, N. D., Othman, R. A., Suh, M., & Moghadasian, M. H. (2009). A systemic review of the roles of n-3 fatty acids in health and disease. Journal of the American Dietetic Association. https://doi.org/10.1016/j.jada.2008.12.022
Vancouver
Riediger ND, Othman RA, Suh M, Moghadasian MH. A systemic review of the roles of n-3 fatty acids in health and disease. Journal of the American Dietetic Association. 2009. doi:10.1016/j.jada.2008.12.022. PMID: 19328262.
BibTeX
@article{riediger2009-19328262,
author = {Riediger, N. D. and Othman, R. A. and Suh, M. and Moghadasian, M. H.},
title = {{A systemic review of the roles of n-3 fatty acids in health and disease}},
journal = {Journal of the American Dietetic Association},
year = {2009},
doi = {10.1016/j.jada.2008.12.022},
pmid = {19328262},
url = {https://doi.org/10.1016/j.jada.2008.12.022}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- Furthermore, additional controlled clinical trials are needed to document whether long-term consumption or supplementation with eicosapentaenoic acid/docosahexaenoic acid or the plant-derived counterpart (alpha-linolenic acid) results in better quality of life.
Why it matters
This review says n-3 fatty acids have been studied for several conditions including dementia, but that more controlled trials are needed to show whether long-term consumption or supplements improve quality of life. It provides no evidence that these fatty acids treat or prevent Alzheimer's disease.
New to this subject? Start with our plain-English guide: Risk factors, ranked →
Study details
- Evidence strengthLow
How this study scored 56/100
Published in a peer-reviewed journal, and it is a systematic review of all the studies on the question. Scored zero for sample size, effect reported and studied in people because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Journal of the American Dietetic Association) |
| Journal's citation record | 2 / 4 | Journal of the American Dietetic Association: journal h-index 248 (OpenAlex, 2026-10-29) |
| Study design | 12 / 12 | A systematic review of all the studies on the question (from PubMed type “Systematic Review”) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 1 / 5 | 2009 — within 20 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | A review of other studies — randomization is not credited here |
| Times cited | 6 / 7 | Cited 699 times (OpenAlex, 2026-10-10) |
| Citations per year | 4 / 5 | 36.8 citations a year over 19 year(s) since 2009 |
| Impact for its field and year | 6 / 6 | Cited 52.8× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 2 / 4 | Cited 44 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author Mohammed H. Moghadasian: h-index 39 (OpenAlex, whole career) |
| Institution's track record | 0 / 3 | University of Manitoba: institution h-index 666 (OpenAlex) |
| Multicenter collaboration | 1 / 3 | OpenAlex lists 2 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 19328262) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Total | 56 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
May need a subscription OpenAlex found no free copy of the full text (checked 6 Feb 1020), so the publisher may charge for it. The PubMed abstract is free.
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Related studies in Risk factors from nearby years
Also in Risk factors
389 studies in the library are filed under Risk factors with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The Risk factors hub.